Company

Freya

Rocket Ship Rating

Rocket Ship Rating: 94 out of 100

Driving immune-mediated therapeutic innovation for women

Also known as Freya Biosciences

Biotech & therapeutics
Women's & family health

Status: Operatingas of 2026-09-17
Business model: B2B

freyabiosciences.com (opens in a new tab)
Press page (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Freya Biosciences is a clinical-stage immunology company developing therapies to address inflammation and immune dysregulation in conditions affecting women.

Funding snapshot

Total raised: $38MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round: Series A, $38M2023-07-18

Funding rounds

Series A: $38M2023-07-18, Company stated

Relationships

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.